Forest Laboratories, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Forest Laboratories, Inc. - overview
Location
New York, NY, US
Primary Industry
Pharmaceuticals
About
Forest Laboratories, Inc. is a biopharmaceutical company focused on developing and delivering innovative therapies for a range of health conditions, emphasizing research and development to enhance patient care. Forest Laboratories, Inc. engages in the research, development, and marketing of pharmaceutical products.
Founded by Brenna Thompson and Danielle Jean, the company is headquartered in New York, US. Danielle Jean currently serves as CEO. The company has undergone various strategic pivots to enhance its therapeutic offerings and market presence. Forest Laboratories develops and markets a diverse array of pharmaceutical products targeting critical health issues across therapeutic areas.
Its portfolio includes treatments for chronic and acute conditions, aimed at healthcare providers, hospitals, and specialty pharmacies, thereby reaching patients globally in North America, Europe, Asia, and Latin America. Forest Laboratories generates its revenue primarily through direct sales of its pharmaceutical products to healthcare providers and pharmacies. The pricing strategies applied reflect the value of its products, particularly for established treatments, contributing to its overall financial performance. The company plans to launch new products focused on unmet medical needs in the upcoming quarters.
Future expansions will target markets in Asia and Europe, with efforts expected to be realized by the end of 2024. Recent funding will be utilized to bolster research and development initiatives, supporting these growth strategies.
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceuticals
Website
www.frx.com
Total Amount Raised
Subscriber access only
Forest Laboratories, Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Trade Sale | Completed | Adare Pharma Solutions | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.